VMVarun Mahajan

Varun Mahajan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Varun Mahajan has a total of 82 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Effect of sugammadex versus neostigmine/glycopyrrolate combination on peak expiratory flow rates in adult patients undergoing laparoscopic surgery

    by Penna Srihitha, Vikas Saini, Tanvir Samra, Venkata Ganesh, Varun Mahajan, B Naveen Naik

    Background and Aims: Residual neuromuscular blockade impacts peak expiratory flow rate (PEFR). The primary aim of this study was to compare post-extubation PEFR in adults undergoing laparoscopic cholecystectomy when neuromuscular blockade was reversed by either neostigmine or sugammadex. Methods: Patients aged 18–60 years were randomised into two equal groups of 43 each based on the reversal agent used – sugammadex versus neostigmine. Pre- and post-operative PEFRs were recorded using a handheld flow-type spirometer. Percentage reduction in forced expiratory volume in first second (FEV1), forced vital capacity (FVC), and FEV1/FVC were calculated. Adverse events and recovery scores were compared between the two groups. Results: The post-operative PEFR with sugammadex was 336.88 ± 65.94 L/min, compared to 293.93 ± 43.76 L/min with neostigmine. The mean difference was statistically significant {42.95 L/min [95% confidence interval (CI): 18.95–66.95 L/min], P = 0.001}. The mean percentage reduction in PEFR from baseline was significantly lower with sugammadex (9.66 ± 6.11%) compared to neostigmine (16.33 ± 10.9%). The median time to extubation with sugammadex was 3 min [interquartile range (IQR): 3–4)], and 7 min (IQR: 6–8) with neostigmine ( P = 0.001). The time to achieve modified Aldrete score >8 with sugammadex was shorter by an absolute difference of 8.814 (CI = 10.28–7.35) min. No incidence of post-operative pulmonary complication (PPC) was reported in either group. Conclusion: Reversal of neuromuscular blockade with sugammadex is associated with higher post-operative values of PEFR when compared with neostigmine. Higher values of PEFR and FEV1, FVC, and FEV 1 /FVC ratio after surgery shorten the time to extubation, minimise PPC, and facilitate early post-operative recovery.


  • Utility of Urinary Biomarkers for Diagnosis of Acute Kidney Injury (AKI) in COVID-19

    by Tanvir Samra, Vinod Kumar, Raja Ramachandran, Varun Mahajan, Naveen B. Naik, Goverdhan Dutt Puri, Ashish Bhalla, Arnab Pal, Ravi Dixit, Prabhjot Kaur

    Acute kidney injury (AKI) is a complication of COVID-19 and urinary biomarkers of renal “stress” and “injury” can be utilised for an early diagnosis. In this prospective observational study, critically-ill adult patients with COVID-19 disease from November 2020 to May 2021 were recruited and urine samples collected at the time of admission to ICU, and subsequently at 12, 24 and 48 h and analysed for biomarkers of “renal injury” namely KIM-1, NGAL, IL-18, and cell cycle arrest biomarker IGFBP-7 and TIMP-2 which have been reported to increase following renal stress. Spot urine samples were collected and to adjust for dilution, sample volume and rate of urine production, assays of the biomarkers were normalised by dividing the values with urinary creatinine concentration. The incidence of AKI in our study was 22.64% (24/106). Patients in the AKI group were older with significantly higher requirements for invasive mechanical ventilation, inotropic support, longer hospital stay, and higher mortality. Diagnostic performance of various biomarkers to predict AKI was compared with receiver operator characteristics curve analysis. TIMP-2 × IGFBP7 > 0.301 (ng/ml)2/1000 predicted AKI with sensitivity and specificity of 84.1% and 31.6% (AUC = 0.579, and p < 0.035), respectively. AUC was 0.663 with a p-value < 0.001 when cut-off values after normalisation were > 0.87 (ng/mmol)2/1000. IL-18, TIM-1, NGAL predicted AKI at cut-off values of 24.936, 12,372.766, and 8017.74 ng/mmol with AUC of 0.653 (p ≤ 0.001), 0.646 (p ≤ 0.001), and 0.552 (p = 0.035), respectively. Urinary cell cycle arrest biomarkers have a more promising role over biomarkers of renal injury in identification of patients at risk of AKI.


  • Open Access

    Characteristics and outcomes of pulmonary barotrauma in patients with COVID-19 ARDS: A retrospective observational study

    by Varun Mahajan, Kamal Kajal, Amarjyoti Hazarika, Karan Singla, Naveen Naik B, Ananya Ray, Venkata Ganesh, Ajay Singh, Ashish Bhalla, Goverdhan Dutt Puri

    Introduction: Pulmonary barotrauma in coronavirus disease-2019 (COVID-19) acute respiratory distress syndrome (ARDS) carries high risk of mortality. While various studies have reported increased mortality, few have assessed the contributing factors for the occurrence of this complication. This study aimed at exploring the contributing factors for barotrauma in COVID-19 ARDS. Methodology: In this retrospective study, patients aged ≥18 years with laboratory confirmed severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) by reverse transcriptase polymerase chain reaction (RT-PCR) from a nasopharyngeal swab and having severe or critical COVID-19 disease requiring Intensive Care Unit (ICU) admission according to the World Health Organisation (WHO) criteria for disease severity in COVID-19 disease admitted at forty-bedded ICUs at a tertiary care research hospital in North India from April 1, 2020, to March 31, 2022 were included. Results: Of 825 patients admitted to COVID ICU, 40 developed pulmonary barotrauma, with a mortality rate of 85%. The mean ± SD PaO 2 /FiO 2 was 96.76 ± 27.78 mmHg. Thirty-nine patients received steroids, 37 developed secondary bacterial infection of the lower respiratory tract with one or more organisms. Acinetobacter baumannii ( n = 15), Klebsiella pneumoniae ( n = 10), and Pseudomonas aeruginosa ( n = 8) were the commonest isolates. Ten patients developed pneumomediastinum, of which 6 patients had subcutaneous emphysema along with pneumomediastinum, and 2 patients developed isolated subcutaneous emphysema. The remaining 28 patients developed pneumothorax. The mean (±SD) for static respiratory system compliance (Crs) for patients on mechanical ventilation on the day of barotrauma was 19.3 (±10.5) mL/cmH 2 O. Conclusion: Patients with COVID-19 ARDS developing pulmonary barotrauma have a high associated mortality, and secondary bacterial infection, lung fragility, patient-ventilator asynchrony, as well as low respiratory system compliance, may contribute to lung injury, predisposing to barotrauma.

  • Open Access

    Analysis of Predictors and Outcomes of COVID-19 Patients Requiring ICU Admission from COVID-19 Registry, India

    by Aparna Mukherjee, Mary John, Goverdhan Dutt Puri, Ashish Bhalla, Karan Singla, Kamal Kajal, Varun Mahajan, Pankaj Bhardwaj, Madhumita Premkumar, Geetha R Menon, et al.

    Patients admitted to intensive care units (ICUs) with severe coronavirus disease (COVID-19) are associated with high mortality. The present retrospective, multicenter study describes the predictors and outcomes of COVID-19 patients requiring ICU admission from COVID-19 Registry of Indian Council of Medical Research (ICMR), India. Prospectively collected data from participating institutions were entered into the electronic National Clinical Registry of COVID-19. We enrolled patients aged >18 years with COVID-19 pneumonia requiring ICU admission between March 2020 and August 2021. Exclusion criteria were negative in RT-PCR report, death within 24 hours of ICU admission, or incomplete data. Their demographic and laboratory variables, ICU severity indices, treatment strategies, and outcomes were analyzed. A total of 5,865 patients were enrolled. Overall mortality was 43.2%. Non-survivors were older (58.2 ± 15.4 vs 53.6 ± 14.7 years; p = 0.001), had multiple comorbidities (33.2% vs 29.5%, p = 0.001), had higher median D-dimer (1.56 vs 1.37, p = 0.015), higher CT severity index (16.8 ± 5.2 vs 13.5 ± 5.47, p = 0.001) and longer median hospital stay (10 vs 8 days, p = 0.001) and ICU stay (5 vs 4 days, p = 0.001), compared with survivors. On multivariate analysis, high CRP (HR 1.008, 95% CI: 1.006–1.010, p = 0.001) and high D-dimer (HR 1.089, 95% CI: 1.065–1.113, p < 0.001) were associated with invasive mechanical ventilation while older age (HR 1.19, CI: 1.001–1.038, p = 0.039) and high D-dimer (HR-1.121, CI: 1.072–1.172, p = 0.001) were independently associated with mortality and while the use of prophylactic low molecular weight heparin (LMWH) (HR 0.647, CI: 0.527–0.794, p = 0.001) lowered mortality. Among 5,865 COVID-19 patients admitted to ICU, mortality was 43.5%. High CRP and D-dimers were independently associated with the need for invasive mechanical ventilation while older age and high D-dimer were associated with higher mortality. The use of prophylactic LMWH independently reduced mortality. Kajal K, Singla K, Puri GD, Bhalla A, Mukherjee A, Kumar G, et al. Analysis of Predictors and Outcomes of COVID-19 Patients Requiring ICU Admission from COVID-19 Registry, India. Indian J Crit Care Med 2023;27(8):552–562.


  • Biochemical Predictors of Acute Kidney Injury in Critically Ill COVID-19 Patients

    by Tanvir Samra, Raja Ramachandran, Vinod Kumar, Ananya Ray, Varun Mahajan, Rajarajan Ganesan, Naveen Naik B, Goverdhan Dutt Puri, Ashish Bhalla, Hemant Bhagat

    It is estimated that 50% of patients with coronavirus disease 2019 (COVID-19) have varying degrees of renal involvement. In this clinical biomarker development research, we examined in a retrospective study design the temporal changes in biochemical laboratory parameters in relation to the development of acute kidney injury (AKI). In a sample of 399 patients admitted from May 2020 to May 2021 to a tertiary health care intensive care unit (ICU), the incidence of AKI was 27.3%, and the median time to AKI was on 7th day of ICU admission. Most common etiology of AKI was kidney hypoperfusion. Within 72 h of developmental of low blood pressure, 63.76% developed AKI. The likelihood of AKI was higher in those with elevated serum ferritin, aspartate transaminase, and thrombocytopenia (low platelet count). A cutoff value of 750.3 ng/mL [area under the ROC curve (AUC) = 0.777] for serum ferritin, and 40.05 U/L for alanine aminotransferase (AUC = 0.677) 1 day before development of AKI displayed, respectively, a sensitivity of 76.2% and 64.3%, whereas the specificity was 69.5% and 64.1%, respectively, for these two biochemical predictors. A cutoff value of platelets (152.50 × 10 9 /L [AUC = 0.75]) measured 4 days before development of AKI, displayed 83.3% sensitivity and 16.4% specificity. Taken together, our study thoroughly examined the temporal association of various clinical and laboratory parameters with AKI and prediction models were developed as per results of the time series data. These observations in a tertiary health care setting contribute to ongoing efforts for biomarker discovery and development using routine biochemical tests so as to forecast AKI in patients with COVID-19.


  • Open Access

    Characteristics and outcomes of parturients with COVID-19, admitted to a critical care unit: A single-center retrospective observational study

    by Ananya Ray, Tanvir Samra, Varun Mahajan, Karan Singla, B Naveen Naik, Bharti Joshi, Vighnesh Ashok, Vanita Suri, Mini Singh, Arnab Ghosh, et al.

    A BSTRACT: Background: Data on outcomes of coronavirus disease 2019 (COVID-19) in pregnancy are scarce, although they represent a unique physiological state affecting both the mother and child. We present collated data from a tertiary care center in North India, encompassing the outcome, clinical characteristics, and management of these patients. Materials and Methods: Parturients ≥ 18 years old, with COVID-19 reverse transcriptase polymerase chain reaction positive for severe acute respiratory syndrome coronavirus 2, requiring intensive care unit (ICU) admission at a tertiary care hospital were included. Data were retrospectively collected from April 2020 to November 2021. Results: In all, 26 parturients were admitted to ICU with COVID-19. Five patients were admitted during the first wave, and all were asymptomatic. Twenty-one patients presented during the second wave (March 2021 onward), among which four were asymptomatic and 17 symptomatic (all with severe pneumonia). Three patients presented in the second trimester, all with critical disease, out of which one did not survive. Two patients had twin gestation, and others were singleton pregnancies. Seven patients (27%) were primigravida, and five patients (19.2%) had more than third pregnancy. Twenty critically ill women (77%) delivered during the hospital stay. Six patients died during the second wave, and four deaths (66.7%) were because of COVID-19 acute respiratory distress syndrome (ARDS). Conclusions: The number of admissions and mortality related to COVID-19 ARDS was higher in the second wave than in the first. We report the safe use of remdesivir and tocilizumab in our patients.


  • Quantification of diurnal variation in “glove hygiene” compliance in COVID ICUs: An exploratory study

    by Parakriti Gupta, Manisha Biswal, Rupinder Kaur, Kulbeer Kaur, Harinder Kaur, Manjinder Kaur, Varun Mahajan, G.D. Puri, Rashmi R. Guru, Vipin Kaushal


  • Open Access

    Unmasking the ties of snake bite poisoning and COVID-19

    by Anjuman Chander, Tanvir Samra, Sekar Loganathan, Varun Mahajan

    Background: Snake bite envenoming is a neglected tropical disease with variable clinical presentation, neurotoxic manifestations (respiratory paralysis), rhabdomyolysis, cardiotoxicity, autonomic hyperactivity, and/or coagulation abnormalities. There is limited data on the clinical course of the envenomation in an incidentally diagnosed COVID-19 patient. Case presentation: A 17-year-old male with history of snake bite and neuroparalysis developed shortness of breath. He was treated with lyophilized polyvalent anti-snake venom (ASV) on admission in the emergency department and mechanical ventilation. Subsequently, he tested positive for COVID-19 infection. No immunomodulatory therapy was administered, and patient was extubated on the 5th day of ICU admission without any neurological deficit. Conclusions: Coinfections of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) virus with snake bite poisoning lead to diagnostic dilemmas and controversies in management practices. Abnormalities of coagulation need to be cautiously addressed, and cause of development of pneumonia needs to be identified. The rapid recovery of the patient in our case theoretically can be explained on the organ-protective potential of snake-derived peptides; a large case series is however needed to prove the same.